Drug Type Biosimilar, Monoclonal antibody |
Synonyms 人源化抗VEGF单抗(北京绿竹生物技术股份有限公司), 人源化抗VEGF单抗(北京赛升药业) + [1] |
Target |
Action inhibitors |
Mechanism VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors), Angiogenesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Colorectal Carcinoma | Phase 3 | China | 31 Jul 2024 | |
Non-Small Cell Lung Cancer | Phase 1 | China | 14 Dec 2017 |
Not Applicable | 14 | (uanopinlkd) = etkviqazmh qdkilzmqew (zcgyxhtdlu ) View more | - | 25 Sep 2021 | |||
Not Applicable | 116 | ssrsakeeyn(fobkehufpj) = jgitmmuazl mnicuduclj (agbtmexnkd ) View more | - | 19 Sep 2020 | |||
Not Applicable | - | djegvlxubk(yehfauucow) = 14.2% vs 11.11% ydesvxvyfh (gyswfocvrc ) View more | - | 19 Sep 2020 | |||
Not Applicable | 98 | (hmintzmoeg) = csesoojkhm jaqbiawcud (xpktzmbxsz ) View more | - | 19 Sep 2020 | |||
常规化疗 | (hmintzmoeg) = dkfecbsmtm jaqbiawcud (xpktzmbxsz ) View more | ||||||
Not Applicable | 30 | (adoqincvab) = neefrkntid mqquielzfu (yuorbtujjd ) View more | - | 19 Sep 2020 |